Quarterly report · Q2
4893.TEDINET S100RP80
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks9 of 9 passed
Key figures · 28
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥482m | 2023-01-01 → 2023-06-30 | Standalone | Operating income |
| Ordinary income | −¥832m | 2023-01-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥384m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥832m | 2023-01-01 → 2023-06-30 | Standalone | Income before income taxes |
| Net income | −¥834m | 2023-01-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | −¥387m | 2022-01-01 → 2022-12-31 | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.1bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2022-12-31 | Standalone | Assets |
| Total liabilities | ¥199m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥340m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.9bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.3bn | at 2022-12-31 | Standalone | Net assets |
| Cash and deposits | ¥6.0bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.5bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥6.0bn | at 2023-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥509m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥107m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.9bn | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥488m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-21.03 | 2023-01-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.54 | 2023-04-01 → 2023-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.87 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 96.6% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.5% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 43,202,865 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,579,865 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 284
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都杉並区 | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)大和日台バイオベンチャー投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目９－１ | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)株式会社アプリコット | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都渋谷区千駄ヶ谷４丁目20番１号 神宮北参道プレックス７階 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)荻原 弘子 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)東京都中野区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | Original text (Japanese)1単元(100株)未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は、子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration_NonConsolidatedMember | Original text (Japanese)当社は、がん免疫療法創薬事業の単一セグメントであり、セグメント情報の記載を省略しております。 | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 9 of 9 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |